New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Empowering Hearts, Embracing Life: Celebrating World Heart Day

Empowering Hearts, Embracing Life: Celebrating World Heart Day

World Heart Day, annual observance and celebration held on September 29 that is intended to increase public awareness of cardiovascular diseases, including their prevention and their global impact.
Cardiovascular Diseases September 29,2024
Empowering Hearts, Embracing Life: Celebrating World Heart Day

Empowering Hearts, Embracing Life: Celebrating World Heart Day

World Heart Day, annual observance and celebration held on September 29 that is intended to increase public awareness of cardiovascular diseases, including their prevention and their global impact.
Cardiovascular Diseases September 29,2024
Scholar aims to reverse-engineer cancer with 3D tool

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha
Oncology September 28,2024
Scholar aims to reverse-engineer cancer with 3D tool

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha
Oncology September 28,2024
A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t
Oncology September 28,2024
A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

A novel network computer model to find co-occurring mutations—researchers improve search for cancer drivers

by Tina Hilding,Washington State UniversityNumber of mutations by variant type (A) before filtering and (B) after filtering. (C) Number of genes and their role in cancer. (D) Pie chart showing t
Oncology September 28,2024
Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

byPurdue UniversityBenchmark for evaluating and optimizing existing pathway analysis methods. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51859-9Research from Purdue
Oncology September 28,2024
Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

Computational tool reveals untapped efficacy of cancer drug, leveling up cancer fight

byPurdue UniversityBenchmark for evaluating and optimizing existing pathway analysis methods. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51859-9Research from Purdue
Oncology September 28,2024
'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '
Oncology September 28,2024
'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '
Oncology September 28,2024
Molecular profiling may improve meningioma decision making

Molecular profiling may improve meningioma decision making

by Melissa Rohman,Northwestern UniversityPropensity score matched analysis of degrees of surgical resection in meningioma. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03167
Oncology September 28,2024
Molecular profiling may improve meningioma decision making

Molecular profiling may improve meningioma decision making

by Melissa Rohman,Northwestern UniversityPropensity score matched analysis of degrees of surgical resection in meningioma. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03167
Oncology September 28,2024
Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-
Oncology September 28,2024
Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-
Oncology September 28,2024
Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a be
Oncology September 28,2024
Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a be
Oncology September 28,2024
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang
Oncology September 28,2024
Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang
Oncology September 28,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com